Role of AMP-activated protein kinase in mechanism of metformin action

Journal of Clinical Investigation

Volumn 108, Issue 8, 2001, Pages 1167-1174

  Zhou, G ^a   Myers, R ^a   Li, Y ^a   Chen, Y ^a   Shen, X ^a   Fenyk Melody, J ^a   Wu, M ^a   Ventre, J ^a   Doebber, T ^a   Fujii, N ^a   Musi, N ^a   Hirshman, M F ^a   Goodyear, L J ^a   Moller, D E ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 [4 (2 PIPERIDIN 1 YL ETHOXY)PHENYL)] 3 PYRIDIN 4 YLPYRAZOLO[1,5 A]PYRIMIDINE; ACETYL COENZYME A CARBOXYLASE; ADENOSINE PHOSPHATE ACTIVATED PROTEIN KINASE INHIBITOR; ADENYLATE KINASE; FATTY ACID; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LIPID; MESSENGER RNA; METFORMIN; PROTEIN KINASE; PROTEIN KINASE INHIBITOR; STEROL REGULATORY ELEMENT BINDING PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL KINETICS; CONTROLLED STUDY; DRUG MECHANISM; ENZYME MECHANISM; FATTY ACID OXIDATION; FATTY LIVER; GLUCOSE METABOLISM; GLUCOSE UTILIZATION; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPOGENESIS; LIVER CELL; MALE; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SKELETAL MUSCLE; TRANSCRIPTION REGULATION;

EID: 0034773404     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI13505     Document Type: Article

References (38)

1. Metabolic effects of metformin in non-insulin-dependent diabetes mellitus
2. The antihyperglycaemic effect metformin: Therapeutic and cellular mechanisms
3. Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients
4. Biguanides. A review of history, pharmacodynamics and therapy
5. Mechanism by which metformin reduces glucose production in type 2 diabetes
6. Cellular mechanism of metformin action involves glucose transporter translocation from an intracellular pool to the plasma membrane in L6 muscle cells
7. Effect of metformin on insulin-stimulated glucose transport in isolated skeletal muscle obtained from patients with NIDDM
8. Metformin reverses fatty liver disease in obese, leptin-deficient mice
9. The AMP-activated protein kinase: Fuel gauge of the mammalian cell?
10. AMP-activated protein kinase, a metabolic master switch: Possible roles in type 2 diabetes
11. Evidence For 5' AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport
12. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle
13. AMP-activated protein kinase: A critical signaling intermediary for exercise-stimulated glucose transport?
14. 5-Aminoimidazole-4-carboxamide riboside mimics the effects of insulin on the expression of the 2 key gluconeogenic genes PEPCK and glucose-6-phosphatase
15. AMP-activated protein kinase inhibits the glucose-activated expression of fatty acid synthase gene in rat hepasocytes
16. Chronic activation of 5'-AMP-activated protein kinase increases GLUT-4, hexokinase, and glycogen in muscle
17. Basic cell culture protocols
18. Insulin activation of acetyl-CoA carboxylase accompanied by inhibition of the 5'-AMP-activated protein kinase
19. Tissue distribution of the AMP-activated protein kinase, and lack of activation by cyclic-AMP-dependent protein kinase, studied using a specific and sensitive peptide assay
20. Mitochondrial and peroxisomal fatty acid oxidation in liver homogenates and isolated hepatocytes from control and clofibrate-treated rats
21. Purification and characterization of the AMP-activated protein kinase. Copurification of acetyl-CoA carboxylase kinase and 3-hydroxy-3-methylglutaryl-CoA reductase kinase activities
22. Metabolic stress and altered glucose transport: Activation of AMP-activated protein kinase as a unifying coupling mechanism
23. Independent regulation of sterol regulatory element-binding proteins 1 and 2 in hamster liver
24. Metformin: A review of its metabolic effects
25. Membrane physiology as a basis for the cellular effects of metformin in insulin resistance and diabetes
26. The effect of intravenous metformin on glucose metabolism during hyperglycaemia in type 2 diabetes
27. Subcellular distribution of metformin in rat liver
28. Accumulation of metformin by tissues of the normal and diabetic mouse
29. Metformin: A review of its pharmacological properties and therapeutic use
30. Metformin therapy
31. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain
32. Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I
33. The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis
34. Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice
35. Leptin, troglitazone, and the expression of sterol regulatory element binding proteins in liver and pancreatic islets
36. Diurnal rhythm of phosphorylation of rat liver acetyl-CoA carboxylase by the AMP-activated protein kinase, demonstrated using freeze-clamping. Effects of high fat diets
37. What if Minkowski had been ageusic? An alternative angle on diabetes